Literature DB >> 23133819

Altered sympathetic nervous system signaling in the diabetic heart: emerging targets for molecular imaging.

James T Thackeray1, Rob S Beanlands, Jean N Dasilva.   

Abstract

Diabetes is commonly associated with increased risk of cardiovascular morbidity and mortality. Perturbations in sympathetic nervous system (SNS) signaling have been linked to the progression of diabetic heart disease. Glucose, insulin, and free fatty acids contribute to elevated sympathetic nervous activity and norepinephrine release. Reduced left ventricular compliance and impaired cardiac function lead to further SNS activation. Chronic elevation of cardiac norepinephrine culminates in altered expression of pre- and post-synaptic sympathetic signaling elements, changes in calcium regulatory proteins, and abnormal contraction-excitation coupling. Clinically, these factors manifest as altered resting heart rate, depressed heart rate variability, and impaired cardiac autonomic reflex, which may contribute to elevated cardiovascular risk. Development of molecular imaging probes enable a comprehensive evaluation of cardiac SNS signaling at the neuron, postsynaptic receptor, and intracellular second messenger sites of signal transduction, providing mechanistic insights into cardiac pathology. This review will examine the evidence for abnormal SNS signaling in the diabetic heart and establish the physiological consequences of these changes, drawing from basic biological research in isolated heart and rodent models of diabetes, as well as from clinical reports. Particular attention will be paid to the use of molecular imaging approaches to non-invasively characterize and evaluate sympathetic signal transduction in diabetes, including pre-synaptic norepinephrine reuptake assessment using (11)C-meta-hydroxyephedrine ((11)C-HED) with PET or (123)I-metaiodobenzylguanidine ((123)I-MIBG) with SPECT, and postsynaptic β-adrenoceptor density measurements using CGP12177 derivatives. Finally, the review will attempt to define the future role of these non-invasive nuclear imaging techniques in diabetes research and clinical care.

Entities:  

Keywords:  SNS signaling; Sympathetic neuronal imaging; norepinephrine; norepinephrine reuptake transporter; β-adrenoceptor

Year:  2012        PMID: 23133819      PMCID: PMC3477737     

Source DB:  PubMed          Journal:  Am J Nucl Med Mol Imaging


  143 in total

1.  Cardiovascular autonomic function in conscious rats: a novel approach to facilitate stationary conditions.

Authors:  Dirk Ramaekers; Frank Beckers; Hilde Demeulemeester; André E Aubert
Journal:  Ann Noninvasive Electrocardiol       Date:  2002-10       Impact factor: 1.468

2.  A new method for measurement of blood pressure, heart rate, and activity in the mouse by radiotelemetry.

Authors:  P A Mills; D A Huetteman; B P Brockway; L M Zwiers; A J Gelsema; R S Schwartz; K Kramer
Journal:  J Appl Physiol (1985)       Date:  2000-05

3.  beta-Adrenergic receptors, adenylate cyclase activity, and cardiac dysfunction in the diabetic rat.

Authors:  F L Atkins; R T Dowell; S Love
Journal:  J Cardiovasc Pharmacol       Date:  1985 Jan-Feb       Impact factor: 3.105

4.  The effect of streptozotocin-induced diabetes on cardiac beta-adrenoceptor subtypes in the rat.

Authors:  D J Sellers; R Chess-Williams
Journal:  J Auton Pharmacol       Date:  2001-02

5.  Short-term effects of streptozotocin-induced diabetes on the electrocardiogram, physical activity and body temperature in rats.

Authors:  F C Howarth; M Jacobson; O Naseer; E Adeghate
Journal:  Exp Physiol       Date:  2005-01-07       Impact factor: 2.969

Review 6.  Cardiac sympathetic neuronal imaging using PET.

Authors:  Riikka Lautamäki; Dnyanesh Tipre; Frank M Bengel
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-06       Impact factor: 9.236

7.  Carbon-11 hydroxyephedrine with positron emission tomography for serial assessment of cardiac adrenergic neuronal function after acute myocardial infarction in humans.

Authors:  K C Allman; D M Wieland; O Muzik; T R Degrado; E R Wolfe; M Schwaiger
Journal:  J Am Coll Cardiol       Date:  1993-08       Impact factor: 24.094

8.  Abnormal sympathetic innervation of viable myocardium and the substrate of ventricular tachycardia after myocardial infarction.

Authors:  Tetsuo Sasano; M Roselle Abraham; Kuan-Cheng Chang; Hiroshi Ashikaga; Kevin J Mills; Daniel P Holt; John Hilton; Stephan G Nekolla; Jun Dong; Albert C Lardo; Henry Halperin; Robert F Dannals; Eduardo Marbán; Frank M Bengel
Journal:  J Am Coll Cardiol       Date:  2008-06-10       Impact factor: 24.094

9.  Evidence for pre- to postsynaptic mismatch of the cardiac sympathetic nervous system in ischemic congestive heart failure.

Authors:  James H Caldwell; Jeanne M Link; Wayne C Levy; Jeanne E Poole; John R Stratton
Journal:  J Nucl Med       Date:  2008-01-16       Impact factor: 10.057

10.  Sympathetic nervous dysregulation in the absence of systolic left ventricular dysfunction in a rat model of insulin resistance with hyperglycemia.

Authors:  James T Thackeray; Jerry Radziuk; Mary-Ellen Harper; Erik J Suuronen; Kathryn J Ascah; Rob S Beanlands; Jean N Dasilva
Journal:  Cardiovasc Diabetol       Date:  2011-08-10       Impact factor: 9.951

View more
  8 in total

Review 1.  The Type 2 Diabetic Heart: Its Role in Exercise Intolerance and the Challenge to Find Effective Exercise Interventions.

Authors:  J Chris Baldi; Genevieve A Wilson; Luke C Wilson; Gerard T Wilkins; Regis R Lamberts
Journal:  Sports Med       Date:  2016-11       Impact factor: 11.136

2.  Lack of miR-133a Decreases Contractility of Diabetic Hearts: A Role for Novel Cross Talk Between Tyrosine Aminotransferase and Tyrosine Hydroxylase.

Authors:  Shyam Sundar Nandi; Hong Zheng; Neeru M Sharma; Hamid R Shahshahan; Kaushik P Patel; Paras K Mishra
Journal:  Diabetes       Date:  2016-07-13       Impact factor: 9.461

3.  Preclinical characterization of a novel radiolabeled analog of practolol for the molecular imaging of myocardial β-adrenoceptor density.

Authors:  Eric Carbonnelle; Véronique Josserand; Laurent M Riou; Olivier Ormezzano; Alexis Broisat; Pascale Perret; Gilles Barone-Rochette; Daniel Fagret; Catherine Ghezzi
Journal:  J Nucl Cardiol       Date:  2014-05-30       Impact factor: 5.952

4.  Association of Early-Life Factors With Life-Course Trajectories of Resting Heart Rate: More Than 6 Decades of Follow-up.

Authors:  Celia O'Hare; Diana Kuh; Rebecca Hardy
Journal:  JAMA Pediatr       Date:  2018-04-02       Impact factor: 16.193

5.  The co-occurrence of myocardial dysfunction and peripheral insensate neuropathy in a streptozotocin-induced rat model of diabetes.

Authors:  Maria N Marangoni; Scott T Brady; Shamim A Chowdhury; Mariann R Piano
Journal:  Cardiovasc Diabetol       Date:  2014-01-11       Impact factor: 9.951

6.  Role of peripheral 5-HT5A receptors in 5-HT-induced cardiac sympatho-inhibition in type 1 diabetic rats.

Authors:  José Ángel García-Pedraza; Oswaldo Hernández-Abreu; Asunción Morán; José Carretero; Mónica García-Domingo; Carlos M Villalón
Journal:  Sci Rep       Date:  2020-11-09       Impact factor: 4.379

7.  Remodelling of the intracardiac ganglia in diabetic Goto-Kakizaki rats: an anatomical study.

Authors:  Darius Batulevicius; Thomas Frese; Elmar Peschke; Dainius H Pauza; Vaida Batuleviciene
Journal:  Cardiovasc Diabetol       Date:  2013-06-07       Impact factor: 9.951

Review 8.  Neurobiology of Cancer: the Role of β-Adrenergic Receptor Signaling in Various Tumor Environments.

Authors:  Boris Mravec; Lubica Horvathova; Luba Hunakova
Journal:  Int J Mol Sci       Date:  2020-10-26       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.